Evidence map›Paper›PMID 24886709›Full record

ArticleNature communications2014

Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.

Arthur Ko, Rita M Cantor, Daphna Weissglas-Volkov, Elina Nikkola, Prasad M V Linga Reddy, Janet S Sinsheimer, Bogdan Pasaniuc, Robert Brown, Marcus Alvarez, Alejandra Rodriguez and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Role of ChREBP-PPARα-FGF21 Axis in Metabolic Dysfunction of MASLD.International journal of molecular sciences · 2025
    Article
  6. Admixture Mapping of Lipid Traits in Hispanic Americans.Journal of the American Heart Association · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 3 countries.

Arthur Ko1] Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA [2] Molecular Biology Institute at UCLA, Los Angeles, California 90095, USA.
Rita M CantorDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Daphna Weissglas-VolkovDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Elina NikkolaDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Prasad M V Linga ReddyDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Janet S SinsheimerDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Bogdan Pasaniuc1] Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA [2] Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA [3] Bioinformatics Interdepartmental Program, UCLA, Los Angeles, California 90095, USA.
Robert BrownBioinformatics Interdepartmental Program, UCLA, Los Angeles, California 90095, USA.
Marcus AlvarezDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Alejandra RodriguezDepartment of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Rosario Rodriguez-Guillen1] Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico [2] Instituto de Investigaciones Biomédicas de la UNAM, 04510 04510 Mexico City, Mexico.
Ivette C BautistaInstituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico.
Olimpia Arellano-CamposInstituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico.
Linda L Muñoz-HernándezInstituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico.
Veikko SalomaaNational Institute for Health and Welfare, 00271 Helsinki, Finland.
Jaakko Kaprio1] National Institute for Health and Welfare, 00271 Helsinki, Finland [2] Department of Public Health, Hjelt Institute, University of Helsinki, 00014 Helsinki, Finland [3] Institute for Molecular Medicine Finland FIMM, University of Helsinki, 00014 Helsinki, Finland.
Antti JulaNational Institute for Health and Welfare, 00271 Helsinki, Finland.
Matti JauhiainenNational Institute for Health and Welfare, 00271 Helsinki, Finland.
Markku HeliövaaraNational Institute for Health and Welfare, 00271 Helsinki, Finland.
Olli Raitakari1] Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, 20520 Turku, Finland [2] Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, 20520 Turku, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories and University of Tampere School of Medicine, 33100 Tampere, Finland.
Johan G Eriksson1] National Institute for Health and Welfare, 00271 Helsinki, Finland [2] Folkhälsan Research Center, University of Helsinki, 00290 Helsinki, Finland [3] Department of General Practice and Primary Health Care, University of Helsinki, 00014 Helsinki, Finland.
Markus Perola1] National Institute for Health and Welfare, 00271 Helsinki, Finland [2] Institute for Molecular Medicine Finland FIMM, University of Helsinki, 00014 Helsinki, Finland [3] University of Tartu, Estonian Genome Center, 51010 Tartu, Estonia.
Kirk E LohmuellerDepartment of Ecology and Evolutionary Biology, UCLA, Los Angeles, California 90095, USA.
Niina MatikainenDepartment of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Marja-Riitta TaskinenDepartment of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Maribel Rodriguez-TorresInstituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico.
Laura Riba1] Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico [2] Instituto de Investigaciones Biomédicas de la UNAM, 04510 04510 Mexico City, Mexico.
Teresa Tusie-Luna1] Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico [2] Instituto de Investigaciones Biomédicas de la UNAM, 04510 04510 Mexico City, Mexico.
Carlos A Aguilar-SalinasInstituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran, 14000 Mexico City, Mexico.
Päivi Pajukanta1] Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA [2] Molecular Biology Institute at UCLA, Los Angeles, California 90095, USA.
University of California, Los Angeles · USFinnish Institute for Health and Welfare · FIInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversity of Helsinki · FITampere University · FIUniversity of Turku · FI

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 1985 to 2019
$50.2M
STATISTICAL METHODS FOR GENE MAPPINGR01GM053275 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LANGE, KENNETH L · 1995 to 2019
$9.3M
UCLA MSD ProgramR25GM055052 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARBER, PAUL HENRY, HASSON, TAMA W. · 1996 to 2021
$9.2M
Training Grant in Genomic Analysis and InterpretationT32HG002536 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Valerie A Arboleda, Harold Pimentel · 2002 to 2026
$8.6M
The development of alcohol misuse and related problems from adolescence to early midlifeR01AA015416 · NIAAA · WASHINGTON UNIVERSITY · PI DICK, DANIELLE M, SALVATORE, JESSICA E · 2005 to 2024
$7.6M
Genomics of dyslipidemia in MexicansR01HL095056 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PAJUKANTA, PAIVI · 2009 to 2018
$5.9M
ADOLESCENT ALCOHOL ABUSE: A TWIN-STUDY PERSPECTIVER37AA012502 · NIAAA · TRUSTEES OF INDIANA UNIVERSITY · PI ROSE, RICHARD JOSEPH · 2000 to 2009
$2.9M
Twin, molecular, and developmental approaches to understanding alcohol misuseK02AA018755 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DICK, DANIELLE M · 2010 to 2019
$1.3M
Adolescent Alcohol Abuse: A Twin-Study PerspectiveR01AA012502 · NIAAA · TRUSTEES OF INDIANA UNIVERSITY · PI ROSE, RICHARD JOSEPH · 2013 to 2017
$1.2M
BEHAVIORAL PRECURSORS OF ALCOHOLISM--TWIN FAMILY STUDIESR01AA009203 · NIAAA · INDIANA UNIVERSITY BLOOMINGTON · PI ROSE, RICHARD JOSEPH · 1994 to 1998
–
USE &ABUSE OF ALCOHOL--A BEHAVIOR-GENETICS PERSPECTIVEK05AA000145 · NIAAA · INDIANA UNIVERSITY BLOOMINGTON · PI ROSE, RICHARD JOSEPH · 1992 to 1996
–
NHGRI NIH HHS T32 HG002536NHGRI NIH HHS T32HG002536NHLBI NIH HHS HL-095056NHLBI NIH HHS HL-28481NHLBI NIH HHS P01 HL028481NHLBI NIH HHS R01 HL095056NIAAA NIH HHS AA-12502NIAAA NIH HHS AA15416NIAAA NIH HHS K02 AA018755NIAAA NIH HHS K02AA018755NIAAA NIH HHS K05 AA000145NIAAA NIH HHS R01 AA009203NIAAA NIH HHS R01 AA012502NIAAA NIH HHS R01 AA015416NIAAA NIH HHS R37 AA012502NIGMS NIH HHS GM-053275NIGMS NIH HHS R01 GM053275NIGMS NIH HHS R25 GM055052NIGMS NIH HHS R25GM055052Wellcome TrustWellcome Trust WT089062
6 · The paper itself

Abstract

Dyslipidemia and obesity are especially prevalent in populations with Amerindian backgrounds, such as Mexican-Americans, which predispose these populations to cardiovascular disease. Here we design an approach, known as the cross-population allele screen (CPAS), which we conduct prior to a genome-wide association study (GWAS) in 19,273 Europeans and Mexicans, in order to identify Amerindian risk genes in Mexicans. Utilizing CPAS to restrict the GWAS input variants to only those differing in frequency between the two populations, we identify novel Amerindian lipid genes, receptor-related orphan receptor alpha (RORA) and salt-inducible kinase 3 (SIK3), and three loci previously unassociated with dyslipidemia or obesity. We also detect lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) harbouring specific Amerindian signatures of risk variants and haplotypes. Notably, we observe that SIK3 and one novel lipid locus underwent positive selection in Mexicans. Furthermore, after a high-fat meal, the SIK3 risk variant carriers display high triglyceride levels. These findings suggest that Amerindian-specific genetic architecture leads to a higher incidence of dyslipidemia and obesity in modern Mexicans.

Indexed as

AdultApolipoprotein A-VApolipoproteins ACase-Control StudiesChromosomes, Human, Pair 11Chromosomes, Human, Pair 8DyslipidemiasFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHaplotypesHumansHypercholesterolemiaHypertriglyceridemiaIndians, North AmericanAPOA5 protein, humanApolipoprotein A-VApolipoproteins ALipoprotein LipaseLPL protein, humanNuclear Receptor Subfamily 1, Group F, Member 1Protein KinasesRORA protein, humanSIK3 protein, human

Identifiers

PMID24886709
PMCPMC4062071
OpenAlexW2050897637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.